The FTC is investigating Amazon’s deal to buy One Medical

Amazon’s acquisition of and may take longer than expected. Corresponding and , the Federal Trade Commission is reviewing both acquisitions. The deals, announced within a month, are valued at $1.7 billion and $3.9 billion, respectively, and have the potential to transform two markets at once.

A Medical parent, 1Life Healthcare, said the FTC was investigating Friday’s proposed merger with Amazon, they reported The diary. On the same day, Politically said the commission had also started a review of Amazon’s deal to buy iRobot. According to the outlet, given the detailed questions the FTC has sent to the two companies, a formal investigation is likely. Amazon and iRobot are reportedly preparing for a “potentially lengthy… [and] tedious investigation.” A source Politically spoke to the outlet, saying the review is “far-reaching” and aims to determine whether the deal would give Amazon an unfair advantage in the connected device and retail markets.

At the very least, the FTC could easily delay Amazon by up to a year to close deals. For Amazon, a worst-case scenario would involve complaints from the Commission. Earlier this year, NVIDIA abandoned its proposal after the FTC sued to block the purchase over concerns it would stifle competition in a variety of markets. Whatever comes next, Amazon won’t have an easy road ahead. The FTC chairman is a well-known corporate critic. She became known in legal circles on the back of an article with the title “.”

All products recommended by Engadget are selected by our editorial team independently from our parent company. Some of our stories contain affiliate links. If you buy something through one of these links, we may receive an affiliate commission.

https://www.engadget.com/ftc-investigating-amazon-buyout-of-one-medical-irobot-180221944.html?src=rss The FTC is investigating Amazon’s deal to buy One Medical

Russell Falcon

USTimesPost.com is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – admin@ustimespost.com. The content will be deleted within 24 hours.

Related Articles

Back to top button